Shilpa Medicare Gets NCLT Nod for Merger with INM Technologies

Shilpa Medicare Gets NCLT Nod for Merger with INM Technologies Shilpa Medicare has received approval from the National Company Law Tribunal (NCLT), Bengaluru Bench, for its proposed merger with its wholly owned subsidiary, INM Technologies Pvt. Ltd. This move is part of the company’s internal restructuring strategy aimed at streamlining operations and consolidating its R&D and tech-driven verticals under a single umbrella. Why this matters: The merger is expected to enhance operational efficiency, reduce redundancies, and improve resource allocation across the group. INM Technologies, which focuses on innovation and advanced drug delivery systems, will now be fully integrated into Shilpa’s core business, potentially accelerating product development and market responsiveness.